Skip to main content
. 2017 Dec 27;9(42):26625–26637. doi: 10.18632/oncotarget.23803

Figure 5. CTS decreases α-SMA but retains E-cadherin in TGF-β1-treated NRK52E cells for 24 h.

Figure 5

(A) Representative images of immunofluorescence staining for α-SMA and E-cadherin. Original magnification ×630. (B) Representative images of Western blot for α-SMA and E-cadherin. (C) Semiquantitative analysis of Western blot for α-SMA and E-cadherin. *P < 0.05 vs. control, #P < 0.05 vs. the former group.